Author/Authors :
Vasheghani Farahani, Ali Department of Pharmacoeconomics and Pharmaceutical Management - School of Pharmacy - Shahid Beheshti University of Medical Sciences - Tehran, Iran , Rasekh, Hamid Reza Department of Pharmacoeconomics and Pharmaceutical Management - School of Pharmacy - Shahid Beheshti University of Medical Sciences - Tehran, Iran , Rahimi, Farimah Department of Pharmacoeconomics and Pharmaceutical Management - School of Pharmacy - Shahid Beheshti University of Medical Sciences - Tehran, Iran , Najafi, Sheyda College of Pharmacy - Tehran University of medical science - Tehran, Iran , Akbari, Maryam College of Pharmacy - Tehran University of medical science - Tehran, Iran , Salehnia, Faegheh College of Pharmacy - Tehran University of medical science - Tehran, Iran , Hemati, Homa College of Pharmacy - Tehran University of medical science - Tehran, Iran , Jalali, Fatemeh College of Pharmacy - Tehran University of medical science - Tehran, Iran
Abstract :
Cardiovascular disease is one of the most important causes of death in the world. There are variety of plans and strategies to treatment and prevention of CVD. Medicines have significant role in reaching the goals. Ensuring affordability of medicines is very crucial to success in these programs. The impoverishment method which focuses on the impoverishing effect of the purchasing of medicines is one of the most popular methods to quantifying affordability of medicines. We applied this method to measure affordability of cardiovascular medicines in Iran. We used two poverty lines 1.25 USD and 2 USD per day which are recommended by World Bank to access the affordability of medicines. Mono therapy with one anti platelet, Beta blocker, ACE inhibitor and Statin as well as combination therapy have been determined. Our study highlighted that the poorest households in Iran would be at risk of pushing under poverty line because of price of the medicines
Keywords :
Evaluation of Affordability , Impoverishment Effect , Cardiovascular Medicines , Iran
